
Oscar Health, Inc. (OSCR) closed the most recent trading day at $31.29, moving 2.61% from the previous trading session.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Oscar Health, Inc. (OSCR) closed the most recent trading day at $31.29, moving 2.61% from the previous trading session.

CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.

Oscar Health, Inc. (NYSE:OSCR) shares closed 11.9% lower at $26.54 on August 6, even after the insurer reported its most profitable first half and raised its full-year outlook. Second-quarter revenue rose 70% year over year to $4.88 billion, while the company swung to net income of $361.8 million from a $228.4 million loss. The stock […]
Investors pay particular attention to a health insurer’s second-quarter report, which reflects more medical claims data among members.
Oscar Health, Inc. (OSCR) reached $29.5 at the closing of the latest trading day, reflecting a -4.13% change compared to its last close.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Oscar Health (OSCR) has been in focus after the Centers for Medicare & Medicaid Services cut user fees for Affordable Care Act marketplaces, alongside first quarter results that included 147% net income growth and 52% revenue growth year over year. See our latest analysis for Oscar Health. The CMS fee cuts and strong first quarter figures have coincided with a sharp shift in sentiment, with Oscar Health posting a 37.71% 1 month share price return and a 59.77% 1 year total shareholder return...
Klaviyo delivers cloud-based marketing automation tools to businesses worldwide, powering personalized digital communications at scale.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.